Immunosuppressive effects of different calcium channel blockers in human kidney allografts.
Carozzi
S
S
Nephrology and Dialysis Department, St Paul's Hospital, Savona, Italy.
Nasini
M G
MG
Pietrucci
A
A
Nocera
A
A
Fontana
I
I
Valente
U
U
D002118:Calcium / Q000097:blood; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood; D004110:Diltiazem / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017275:Isradipine / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology / Q000378:metabolism; D011239:Prednisolone / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014700:Verapamil / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D016207:Cytokines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D014700:Verapamil; D004110:Diltiazem; D002118:Calcium; D017275:Isradipine